-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Tenax Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2010 to Q1 2023.
- Tenax Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$1.72M, a 41.3% increase year-over-year.
- Tenax Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$5.9M, a 48.2% increase from 2022.
- Tenax Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$11.4M, a 4.9% decline from 2021.
- Tenax Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$10.9M, a 17.1% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)